These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rapid induction of amphotericin B sensitivity in L1210 leukaemia cells by liposomes containing ergosterol. Schiffman FJ; Klein I Nature; 1977 Sep; 269(5623):65-6. PubMed ID: 561318 [No Abstract] [Full Text] [Related]
3. Ergosterol-conferred sensitivity to amphotericin B in cultured K1210 mouse leukemia cells. Schiffman FJ; Fisher JM; Rabinovitz M Biochem Pharmacol; 1977 Feb; 26(3):177-80. PubMed ID: 843388 [No Abstract] [Full Text] [Related]
4. Deoxycholate or amphotericin B in chemotherapy sensitization. Reich SD Ann Intern Med; 1977 May; 86(5):656-7. PubMed ID: 851322 [No Abstract] [Full Text] [Related]
5. Effects of amphotericin B on adriamycin and melphalan cytotoxicity in human and murine ovarian carcinoma and in L1210 leukemia. Ozols RF; Hogan WM; Grotzinger KR; McCoy W; Young RC Cancer Res; 1983 Mar; 43(3):959-64. PubMed ID: 6825115 [No Abstract] [Full Text] [Related]
11. Basic cancer chemotherapy: obstacles and future pharmacologic aspects and selective toxicity. Goldin A Cancer Clin Trials; 1978; 1(2):119-27. PubMed ID: 757140 [No Abstract] [Full Text] [Related]
12. Enhancement of the fungicidal activity of amphotericin B by allicin: effects on intracellular ergosterol trafficking. Ogita A; Fujita K; Tanaka T Planta Med; 2009 Feb; 75(3):222-6. PubMed ID: 19053016 [TBL] [Abstract][Full Text] [Related]
13. Amphotericin B potentiation of the cytotoxicity of anticancer agents against both normal hematopoietic and leukemia cells in mice. Valeriote F; Medoff G; Tolen S; Dieckman J J Natl Cancer Inst; 1984 Aug; 73(2):475-82. PubMed ID: 6589439 [TBL] [Abstract][Full Text] [Related]
14. [Relation between structure and cytotoxic activity of panaxydol analogs against L1210 cells]. Ahn BZ; Kim SI Arch Pharm (Weinheim); 1988 Feb; 321(2):61-3. PubMed ID: 3369927 [No Abstract] [Full Text] [Related]
15. Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP). Hrubisko M; Ujházy V Neoplasma; 1990; 37(6):631-8. PubMed ID: 2274083 [TBL] [Abstract][Full Text] [Related]
16. [Potentiation of the antitumor action of alkylating compounds by amphotericin B]. Iaremenko KV; Eremeeva AA; Tereshin IM Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957 [No Abstract] [Full Text] [Related]
17. Cell-kill kinetics of several S-phase-specific drugs. Bhuyan BK; Fraser TJ; Gray LG; Kuentzel SL; Neil GL Cancer Res; 1973 Apr; 33(4):888-94. PubMed ID: 4735241 [No Abstract] [Full Text] [Related]
18. Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells. Sorace RA; Sheid B Cancer Treat Rep; 1979 Jan; 63(1):43-51. PubMed ID: 421232 [No Abstract] [Full Text] [Related]
19. Rational use of chemotherapy. It is not just rat poison. Kamradt JM; Klein EA; Pienta KJ Urol Clin North Am; 1999 May; 26(2):275-9, vii. PubMed ID: 10361550 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of DL-threo-beta-fluoroasparagine against human leukemia cells in culture and L1210 cells in DBA mice. Stern AM; Abeles RH; Tashjian AH Cancer Res; 1984 Dec; 44(12 Pt 1):5614-8. PubMed ID: 6498822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]